refludan
celgene europe ltd. - lepirudin - thromboembolism; thrombocytopenia - antithrombotic agents - anticoagulation in adult patients with heparin-induced thrombocytopenia type ii and thromboembolic disease mandating parenteral antithrombotic therapy.the diagnosis should be confirmed by the heparin-induced platelet activation assay or an equivalent test.
istodax
celgene europe ltd. - romidepsin - lymphoma, non-hodgkin - antineoplastic agents - treatment of peripheral t-cell lymphoma (ptcl),
thalidomide celgene 50mg capsules
celgene ltd - thalidomide - capsule - 50mg
azacitidine celgene
celgene europe bv - azacitidine - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastic agents - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
vidaza 100mg powder for suspension for injection vials
celgene ltd - azacitidine - powder for suspension for injection - 100mg
imnovid 1mg capsules
celgene ltd - pomalidomide - capsule - 1mg
imnovid 2mg capsules
celgene ltd - pomalidomide - capsule - 2mg
imnovid 3mg capsules
celgene ltd - pomalidomide - capsule - 3mg
imnovid 4mg capsules
celgene ltd - pomalidomide - capsule - 4mg
otezla tablets treatment initiation pack
celgene ltd - not applicable